Current Pharmaceutical Design
Title:Editorial: Natural Products as the Integral Part of the Therapy?
Volume: 23 Issue: 17
Author(s): Maciej Banach*, Dimitri P. Mikhailidis, Maria-Corina Serban and Amirhossein Sahebkar
Affiliation:
- Department of Hypertension WAM University Hospital in Lodz Medical University of Lodz Zeromskiego 113; 90-549 Lodz,Poland
Export Options
About this article
Cite this article as:
Banach Maciej*, Mikhailidis P. Dimitri , Serban Maria-Corina and Sahebkar Amirhossein , Editorial: Natural Products as the Integral Part of the Therapy?, Current Pharmaceutical Design 2017; 23 (17) . https://dx.doi.org/10.2174/1381612823999170404122553
DOI https://dx.doi.org/10.2174/1381612823999170404122553 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-Inflammatory Effects of Fibrates: An Overview
Current Medicinal Chemistry Telemedicine, Genomics and Personalized Medicine: Synergies and Challenges
Current Pharmacogenomics and Personalized Medicine Aberrant DNA Methylation Pattern may Enhance Susceptibility to Migraine: A Novel Perspective
CNS & Neurological Disorders - Drug Targets The Role of Apelins in the Physiology of the Heart
Protein & Peptide Letters Oxidative Brain Damage by Peroxynitrite in Bacterial Meningitis: A Target for Adjunctive Therapy?
Current Medicinal Chemistry - Central Nervous System Agents The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Atherosclerosis
Current Stem Cell Research & Therapy Moxifloxacin-induced Hypoglycemia in a Non-diabetic Patient
Current Drug Safety “Tripping out” with the TRP Superfamily and TRPV1 for Novel Neuroprotection
Current Neurovascular Research Design and Optimization of Chronotherapeutic Dosage Form for the Treatment of Angina Pectoris
Drug Delivery Letters 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities
Mini-Reviews in Medicinal Chemistry Role of Ischemic Blood-Brain Barrier on Amyloid Plaques Development in Alzheimers Disease Brain
Current Neurovascular Research Conditional Cardiac Overexpression of S100A6 Attenuates Myocyte Hypertrophy and Apoptosis Following Myocardial Infarction
Current Pharmaceutical Design Cardiac Biomarkers in Stroke, Alzheimer’s Disease, and Other Dementia. Are They of Use? A Brief Overview of Data from Recent Investigations
CNS & Neurological Disorders - Drug Targets SIRT1 as a Promising Novel Therapeutic Target for Myocardial Ischemia Reperfusion Injury and Cardiometabolic Disease
Current Drug Targets Patents on Nanoparticulate Drug Delivery Systems - A Review
Recent Patents on Drug Delivery & Formulation NADPH Oxidase and Neurodegeneration
Current Neuropharmacology 58-Year Old Men with Non-Stenotic Carotid Artery Plaques and the Relationship with Cardiovascular Risk Factors and Future Cardiovascular Events
Vascular Disease Prevention (Discontinued) Statin Treatment and Carotid Plaque Composition: A Review of Clinical Studies
Current Vascular Pharmacology Which Drugs for the Control of Fever in Critical Patients
Current Drug Targets Periodontitis and Redox Status: A Review
Current Pharmaceutical Design